Bioanalysis , Effect and safety of DCV/ASV in hemodialysis patients infected with HCV: Pilot Study
Phase 2
- Conditions
- Chronic hepatitis C in hemodialysis
- Registration Number
- JPRN-UMIN000015539
- Lead Sponsor
- Hiroshima liver study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Autoimmune hepatitis 2)History of hypersensitivity to DCV and ASV 3)Decompenstated liver cirrhosis 4)HCC, malignat tumor 5)Pregnant or lactating women and women who may be pregnant 6)Judged by investigator not to be appropriate for inclusion in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method